Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Submitted by
admin
on November 14, 2014 - 11:03am
Source:
Fierce Biotech
News Tags:
Boehringer Ingelheim
Wellpoint
atrial fibrillation
R&D
clinical outcomes
Headline:
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Do Not Allow Advertisers to Use My Personal information
